Covalent Modifiers

JANUARY 28, 2024

Simon C.C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, Hannah Semple, Benjamin C. Whitehurst, Hua Xu, SLAS Discovery, 2024 [link] Covalent hits for drug discovery campaigns are neither fantastic beasts nor mythical creatures, they can be routinely identified through electrophile-first screening campaigns using a suite of different techniques. These include biophysical and biochemical methods, cellular approaches, and DNA-encoded libraries.

DNA 68

DNA Drugs 68

FDA Law Blog: Biosimilars

JANUARY 28, 2024

By Jeffrey N. Gibbs & Steven J. Gonzalez — In a new publication in the Washington Legal Foundation’s (WLF) Legal Backgrounder , we argue that FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs) is vulnerable to legal challenge, once finalized. FDA’s proposed rule has every hallmark of a case subject to the “major questions doctrine,” according to which agency action must be support by clear congressional authorization.

Regulations 62

Regulations Laboratories Government FDA 62

Drug Patent Watch

JANUARY 28, 2024

This chart shows the pharmaceutical companies with the most concentrate dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most concentrate dosed drugs… The post Which pharmaceutical companies have the most concentrate dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals Drugs 59

Perficient: Drug Development

JANUARY 28, 2024

Welcome back to our Universal Design Principle Series! In this edition, we dive into the principle of “Simple and Intuitive Use,” a cornerstone in the quest for inclusive design. Join us as we explore the significance of simplicity in creating user-friendly products and environments that can be easily understood and utilized by individuals of diverse abilities.

Production 52

Production Marketing 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Perficient: Drug Development

JANUARY 28, 2024

Welcome back to our Universal Design Principle Series! In this installment, we turn our attention to the principle of “Perceptible Information,” a guiding principle that emphasizes effective communication for users, regardless of their sensory abilities. Join us as we explore the significance of making information accessible through various modalities, fostering inclusivity in design.

Production 52

Production 52